ACUMETIS
LIVE

Serial Number

99573674

Owner

HERSPIEGEL CONSULTING LLC

Attorney

Jacqueline Lesser

First Use Date

Apr 1, 2026

Filing Date

Dec 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ACUMETIS Trademark

Serial Number: 99573674

ACUMETIS is a trademark filed by HERSPIEGEL CONSULTING LLC on December 31, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

HERSPIEGEL CONSULTING LLC

1020 Stony Hill Road, Suite 200
Yardley, PA 19067

Entity Type: 16

Trademark Details

Filing Date

December 31, 2025

Registration Date

Not Registered

First Use Anywhere

April 1, 2026

First Use in Commerce

April 1, 2026

Goods & Services

Advertising and marketing consultancy; Marketing consultation in the field of pharmaceutical, medical and biotechnology and life sciences fields; Assistance in business management and product commercialization; New product commercialization services; Business consulting, management, and planning services in the field of healthcare provider engagement, data analytics and forecasting, and patient management, for the pharmaceutical and healthcare industries; Public policy consultancy in the field of healthcare, clinical testing, and other pharmaceutical research purposes; Medical cost management; Business management and consulting services for the health care industry, namely, customer service, accounting services, and web-based advertising and marketing services; Business consulting services in the field of integration services, workflow execution and alignment through internal business processes, applications and data sources, product suite and databases consisting of statistics, analytics and intelligence on hospitals, physicians and other healthcare providers and organizations

Medical and scientific research information in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies for clinical research, clinical trials and applications for drug approval; Providing information about medical research in the field of pharmaceuticals; Software as a service (SAAS) services featuring software for artificial intelligence for analyzing data and analytics forecasting; Software as a service (SAAS) services featuring software for creating, building, and managing database management software used to track and analyze drug products and pricing

Downloadable computer software for managing product suites and databases related to metrics, analytics, and intelligence on medical facilities, healthcare personnel, healthcare providers, and healthcare organizations; Downloadable interactive software for providing medical and healthcare information, namely disease awareness, treatment options, drug information, and preventative health and risk assessment content; Downloadable computer software for administering clinical drug and medical device trials and for submitting documentation in connection with clinical trial approval processes; Downloadable computer software for pharmaceutical and medical device product lifecycle information management

Filing History

AMENDMENT TO USE PROCESSING COMPLETE
May 28, 2026 AUPC
USE AMENDMENT FILED
May 28, 2026 IUAF
TEAS AMENDMENT OF USE RECEIVED
May 28, 2026 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 26, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 6, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 30, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 31, 2025 MAFR
NEW APPLICATION ENTERED
Dec 31, 2025 NWAP